This website uses cookies to enhance the user experience.
O

ORPHAN DIAGNOSTICS AS918 081 291

Research
Limited company
C/O Hovda Sofies gate 69 0168 OSLO, Norge

ORPHAN DIAGNOSTICS AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
9 years
since Nov 21, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
69,310
1 share class
Total number of shareholders
11
6 companies, 5 persons

Financials

Total operating income 2023
150,000
NOK
Annual total result 2023
-422,714
NOK
Total equity 2023
-489,543
NOK
Last update: Nov 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
50.17 %
directly 18.64 %
indirectly 31.53 %

Board

NameRoleShares
Contact Person, Board Member
50.17 %
directly 18.64 %
indirectly 31.53 %
Board Member
4.72 %
directly
Board Member
9.11 %
indirectly
Chairman
1.93 %
indirectly

Others

NameRoleShares
H
HJELP REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Contact Person, Board Member
50.17 %
directly 18.64 %
indirectly 31.53 %
-
12.78 %
indirectly
-
10.77 %
indirectly
Board Member
9.11 %
indirectly
Board Member
4.72 %
directly
-
3.16 %
indirectly
-
2.39 %
directly
Chairman
1.93 %
indirectly
-
1.93 %
indirectly
-
1.91 %
directly
Last update: Jun 24, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
O
ORPHAN MEDICAL AS
Ordinary shares
21,856
31.53 %
Ordinary shares
12,919
18.64 %
D
DRUBION AS
Ordinary shares
8,859
12.78 %
M
MALSEN MEDICAL AS
Ordinary shares
7,467
10.77 %
F
FRIHEY AS
Ordinary shares
6,314
9.11 %
Ordinary shares
3,271
4.72 %
N
NEMSESK AS
Ordinary shares
2,680
3.87 %
M
MEDCON AS
Ordinary shares
2,193
3.16 %
Ordinary shares
1,659
2.39 %
Ordinary shares
1,325
1.91 %
Ordinary shares
767
1.11 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
150,000
3,623,500
2,841,188
Annual Total Result
-422,714
-904,176
-1,117,444
Total assets
65,006
816,767
992,311
Total liabilities
554,549
883,596
1,530,263
Total equity
-489,543
-66,829
-537,953

P&L

Year202320222021
Total operating income
150,000
3,623,500
2,841,188
Total operating costs
567,753
4,510,412
3,944,627
Operating result
-417,753
-886,912
-1,103,440
Financial income/costs
-4,961
-17,264
-14,004
Profit before tax
-422,714
-904,176
-1,117,444
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-422,714
-904,176
-1,117,444

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
65,006
816,767
992,311
Total assets
65,006
816,767
992,311
Short term debt
308,399
637,446
1,284,113
Long term debt
246,150
246,150
246,150
Total liabilities
554,549
883,596
1,530,263
Contributed capital
2,189,754
2,189,754
814,454
Retained earnings
-2,679,297
-2,256,583
-1,352,407
Total equity
-489,543
-66,829
-537,953
Total equity and liabilities
65,006
816,767
992,310

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering